医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Mechanisms of Shufeng Jiedu Capsule in treating bacterial pneumonia based on network pharmacology and experimental verification

摘要Objective:The aim of this study was to investigate the underlying mechanism of Shufeng Jiedu Capsule(SFJD)for treating bacterial pneumonia(BP)in vivo based on network pharmacology and experimental verification study.Methods:Network pharmacology was used to screen the active compounds and target genes of SFJD.Then,the multi drug resistance-Pseudomonas aeruginosa(MDR-PA)mice lethal model and MDR-PA pneu-monia model were established to evaluate the therapeutic effects and underlying mechanisms of SFJD.Western blot and ELISA were used to determinate the protein expression level of the IL-17 signaling path-way and JAK/STAT signaling pathway.Results:After screening,172 potential components of SFJD were generated,based on which we con-structed an SFJD-component-target-BP interaction network.The Gene ontology(GO)and Kyoto encyclo-pedia of genes and genomes(KEGG)enrichment revealed that SFJD could regulate the IL-17 signaling pathway and Janus kinase/signal transducer and activator of transcription(JAK/STAT)signaling pathway.Molecular docking showed that the potential target proteins had good combinations with the main active components.SFJD significantly reduced the mortality and prolonged survival days in lethal models.The lung index and pathological changes in the lung were also significantly decreased.SFJD could signifi-cantly decrease the expression of interleukin-17A(IL-17A),TNF receptor associated factor 6(TRAF6),phospho-inhibitor of nuclear factor-kappa B(p-IKB)/inhibitor of NF-κB(IκB),phospho-NF-κB p65(p-NF-κB p65),phospho-protein kinase B(p-AKT)/AKT,phospho-signal transducer and activator of tran-scription 3(p-STAT3)/STAT3,phospho-signal transducer and activator of transcription 1(p-STAT1)/STAT1,and the protein level of interleukin-6(IL-6),tumor necrosis factor α(TNF-α),and IL-1β.Conclusion:Combined with network pharmacology and in vivo study,it was found that SFJD exerted its therapeutic effects on BP by inhibiting the IL-17 pathway and JAK/STAT signaling pathway.This study provides new evidence for SFJD in treatment of BP.

更多
广告
作者 Yingli Xu [1] Lei Bao [1] Ronghua Zhao [1] Zihan Geng [1] Shuran Li [1] Bo Pang [1] Qiyue Sun [1] Shanshan Guo [1] Xiaolan Cui [1] Jing Sun [1] 学术成果认领
作者单位 Institute of Chinese Materia Medica,China Academy of Chinese Medical Sciences,Beijing 100029,China [1]
栏目名称
DOI 10.1016/j.chmed.2024.01.002
发布时间 2024-12-23(万方平台首次上网日期,不代表论文的发表时间)
提交
  • 浏览3
  • 下载0
中草药(英文版)

中草药(英文版)

2024年16卷4期

656-666页

MEDLINEISTICCSCD

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷